NEWS: "Hot Off the Press"
- Alpha Modus Settles Lawsuit Against Walgreens Over In-Store Technology Patents
- ZenaTech Signs Agreements to Acquire Two Florida Companies, Expanding Drone as a Service Footprint into Aviation, Defense, and Power Washing
- Alpha Modus To Expand Retail Ecosystem in Strategic Partnership With VSBLTY Groupe Technologies
- Drone Technology Basics: A Beginner’s Guide
- ZenaTech Unveils New Quantum Computing Division to Accelerate Advanced Drone and Defense Capabilities
- How to Safely Fly a Drone in the Rain
- Alpha Modus Agrees to Preferred Stock Exchange to Eliminate ~$41 Million in Mezzanine Equity, Strengthening Balance Sheet, and Fully Aligning Insider Interests
- ZenaTech Signs Offer to Acquire a Flight School Enabling Complex BVLOS Missions and Potential Drone as a Service (DaaS) US Government and Military Contracts
- Affluence Corporation Strengthens Acquisition Strategy to Drive Scalable Growth
- Smart City Success in Malaysia: A Reproducible Model Powered by thethings.iO – MTi’s IoT Platform
- Alpha Modus Holdings Inc. (NASDAQ: AMOD) Eliminates Variable Rate Debt and Finalizes Capital Structure Cleanup
- Alpha Modus (NASDAQ: AMOD) Secures Exclusive National Rights to Deploy CashXAI’s AI-Driven Financial Kiosks-Aimed to Serve 60M+ Underbanked in America
- AI Chatbots: A Transformative Market Set to Soar Beyond 2026
- Affluence Corporation Issues Shareholder Letter Highlighting Strategic Growth, U.S. Expansion and Financial Reset
- Affluence Corporation Reports Over €6.4 Million in Signed Contracts for H1 2025, Confirms Positive Momentum and Strategic Focus on U.S. Expansion
- Affluence Corporation Subsidiary MTi Secures Over €3 Million in New Contracts Across Europe, Asia, and Central Africa
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by New to The Street TV.
- RMX (Reticulate Micro) Secures GSA Schedule Placement, Enhancing Government Market Access
- IQSTD - IQSTEL Reports Strong Preliminary Q1 2025 Results: Revenue Growth, Margin Expansion, and Strategic Progress Toward NASDAQ Uplisting
- Genprex Signs Exclusive License to Additional Gene Therapy Technology with UTHealth Houston for the Treatment of Glioblastoma
- Reticulate Micro’s VAST Platform to Power Advanced Tactical Video at SOF Week 2025
- Beverage Brands Are Moving From Flavor to Function and It's Paying Off for Investors
- IQSTEL Announces Strategic Decision to Uplist to NASDAQ and Executes Reverse Stock Split to Meet Minimum Listing Requirements
- iQSTEL Announces Reverse Stock Split in Preparation for Uplist to Nasdaq
- Top Penny Stocks To Watch In May 2025
- NIP Group Inc (NIPG) (Q4 2024) Earnings Call Highlights: Navigating Growth and Challenges in a ...
- Full Year 2024 NIP Group Inc Earnings Call
- Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting
- NIP Group Inc. Reports Second Half and Full Year 2024 Unaudited Financial Results
- Cycurion, Inc. Announces $6 Million Contract Award by Major Municipal Transportation Agency
- Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting
- Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
- NIP Group to Report Unaudited Financial Results for the Second Half and Full Year 2024 on April 30, 2025
- Forget Sugary Sodas Wellness Drinks Are Gaining Ground With Consumers and Investors
- Ascent Solar Technologies Hosts Customer and Partner Discussions During Space Symposium
- Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting
- Reticulate Micro, Inc. Completes Acquisition of Remaining RMX Industries Inc. Shares, Consolidates Operations, and Expands Leadership Team
- Green Leaf Innovations Announces Q1 Corporate Update and Board Resolution
- Northann Corp. Receives NYSE Notice Regarding Late Filing of Annual Report on Form 10-K
